MedTrace Logo

Genetic Testing for Men With Metastatic Prostate Cancer

NCT03503097 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 799

Last updated 2025-10-01

No results posted yet for this study

Summary

This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns about genetic testing, to determine if this is an acceptable way to deliver testing and to potentially help guide the participant's treatment. Neither treatment nor any decisions related to treatment will take place on this study, but researchers will share each participant's genetic testing results with that participant.

Conditions

  • Metastatic Prostate Carcinoma
  • Stage IV Prostate Cancer AJCC v8
  • Stage IVB Prostate Cancer AJCC v8

Interventions

PROCEDURE

Biospecimen Collection

Provide saliva samples

OTHER

Genetic Counseling

Undergo counseling

OTHER

Genetic Testing

Undergo genetic testing

OTHER

Laboratory Biomarker Analysis

Correlative studies

BEHAVIORAL

Questionnaire

Complete questionnaire

Sponsors & Collaborators

Principal Investigators

  • Heather H. Cheng · Fred Hutch/University of Washington Cancer Consortium

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-21
Primary Completion
2024-08-21
Completion
2025-09-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03503097 on ClinicalTrials.gov